A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management

Immunotherapy has emerged as a highly effective treatment for numerous cancers. Use of checkpoint inhibitors against various molecules including programmed cell death protein‐1 (PD‐1), programmed death ligand‐1 (PD‐L1), and cytotoxic T‐lymphocyte‐associated protein‐4 have become widespread in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Adriana T., Geskin, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Immune‐Related Adverse Events
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263133/
https://www.ncbi.nlm.nih.gov/pubmed/30018132
http://dx.doi.org/10.1634/theoncologist.2018-0128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263133/
https://www.ncbi.nlm.nih.gov/pubmed/30018132
http://dx.doi.org/10.1634/theoncologist.2018-0128

Ejemplares similares